The FDA has given clearance to Adcentrx Therapeutics’ IND application for an antibody-drug conjugate (ADC) targeting solid ...

Thermo Fisher’s John Lesica discusses how mass spectrometry technology enables scientific breakthroughs in genomics and ...

The FDA has simultaneously granted approval to Astellas’ cancer drug Vyloy and to a companion diagnostic test developed by ...

Wave Life Sciences reports that it has successfully carried out RNA editing in two patients with alpha-1 antitrypsin ...

A report of a case of motor neuropathy in a patient who received the vaccine last year has led the FDA to halt its ...

Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...

From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...

The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has recently opened its new ...

Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...

Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...